3 results match your criteria: "Biostatistics and Prevention Institute University of Zurich Zurich Switzerland.[Affiliation]"
Silphinae (Staphylinidae; carrion beetles) are important contributors to the efficient decomposition and recycling of carrion necromass. Their community composition is important for the provision of this ecosystem function and can be affected by abiotic and biotic factors. However, investigations are lacking on the effects of carrion characteristics on Silphinae diversity.
View Article and Find Full Text PDFLongitudinal Changes in Health-Related Quality of Life in Patients With Atrial Fibrillation.
J Am Heart Assoc
November 2023
Epidemiology, Biostatistics and Prevention Institute University of Zurich Zurich Switzerland.
Background Optimizing health-related quality of life (HRQoL) is an important aim of atrial fibrillation (AF) treatment. Little is known about patients' long-term HRQoL trajectories and the impact of patient and disease characteristics. The aim of this study was to describe HRQoL trajectories in an observational AF study population and in clusters of patients with similar patient and disease characteristics.
View Article and Find Full Text PDFSodium-Glucose Cotransporter 2 Inhibitors, All-Cause Mortality, and Cardiovascular Outcomes in Adults with Type 2 Diabetes: A Bayesian Meta-Analysis and Meta-Regression.
J Am Heart Assoc
September 2021
Department of Medicine and Institute of Health Policy, Management and Evaluation Applied Health Research Centre (AHRC) Li Ka Shing Knowledge Institute of St. Michael's HospitalUniversity of Toronto Canada.
Article Synopsis
- This study analyzed how effective sodium-glucose cotransporter 2 inhibitors (like empagliflozin, canagliflozin, and dapagliflozin) are in lowering death rates and cardiovascular issues in adults with type 2 diabetes.
- A Bayesian meta-analysis of 53 randomized controlled trials showed that these medications significantly reduced the risk of all-cause and cardiovascular mortality compared to placebo.
- While the medications also lowered the risk of heart failure, there was less evidence for their effectiveness in reducing stroke risk, particularly for agents other than canagliflozin.